| Mesenchymal stromal/stem cells: a new era in the cell-based targeted gene therapy of cancer F Marofi, G Vahedi, A Biglari, A Esmaeilzadeh, SS Athari Frontiers in immunology 8, 311773, 2017 | 124 | 2017 |
| Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model A Biglari, D Bataille, U Naumann, M Weller, J Zirger, MG Castro, ... Cancer gene therapy 11 (11), 721-732, 2004 | 99 | 2004 |
| Evaluation of exosomal miR‐9 and miR‐155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells V Kia, M Paryan, Y Mortazavi, A Biglari, S Mohammadi‐Yeganeh Journal of cellular biochemistry 120 (4), 5666-5676, 2019 | 72 | 2019 |
| Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo A Biglari, TD Southgate, LJ Fairbairn, DE Gilham Gene Therapy 13 (7), 602-610, 2006 | 65 | 2006 |
| Generation of insulin‐producing cells from human‐induced pluripotent stem cells using a stepwise differentiation protocol optimized with platelet‐rich plasma SE Enderami, Y Mortazavi, M Soleimani, S Nadri, A Biglari, RN Mansour Journal of cellular physiology 232 (10), 2878-2886, 2017 | 55 | 2017 |
| Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria A Biglari, F Saffari, Z Rashvand, S Alizadeh, R Najafipour, M Sahmani Springerplus 4, 1-5, 2015 | 47 | 2015 |
| Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials M Eugenia-Toledo-Romaní, L Verdecia-Sánchez, M Rodríguez-González, ... Vaccine 40 (31), 4220-4230, 2022 | 46* | 2022 |
| Restoration of miR‐152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT–ERK pathway in colorectal cancer A Ghazanchaei, B Mansoori, A Mohammadi, A Biglari, B Baradaran Journal of cellular physiology 234 (1), 769-776, 2019 | 45 | 2019 |
| Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind … ME Toledo-Romaní, M García-Carmenate, C Valenzuela-Silva, ... The Lancet Regional Health–Americas 18, 2023 | 44 | 2023 |
| Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line L Dawoody Nejad, A Biglari, T Annese, D Ribatti Oncology letters 13 (6), 4475-4480, 2017 | 33 | 2017 |
| GDNF gene-engineered adipose-derived stem cells seeded Emu oil-loaded electrospun nanofibers for axonal regeneration following spinal cord injury K Nejati, D Mehdi, S Ghareghomi, E Mostafavi, A Ebrahimi-Kalan, ... Journal of Drug Delivery Science and Technology 60, 102095, 2020 | 30 | 2020 |
| Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells Y Mortazavi, M Paryan, A Biglari, S Mohammadi-Yeganeh Life sciences 220, 162-168, 2019 | 25 | 2019 |
| Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein … R Puga-Gómez, Y Ricardo-Delgado, C Rojas-Iriarte, ... International Journal of Infectious Diseases 126, 164-173, 2023 | 22 | 2023 |
| Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy. M Akhbari, M Khalili, M Shahrabi-Farahani, A Biglari, F Bandarian Clinical Laboratory 65 (8), 2019 | 22 | 2019 |
| Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-β1 in streptozotocin-induced diabetic rat model MF Jazi, A Biglari, S Mazloomzadeh, P Kingston, A Ramazani, JT Bazzaz, ... Iranian Journal of Basic Medical Sciences 19 (3), 265, 2016 | 21 | 2016 |
| Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults ME Toledo-Romani, M García-Carmenate, L Verdecia-Sánchez, ... Med 3 (11), 760-773. e5, 2022 | 20 | 2022 |
| Efficacy and safety of a protein-based SARS-CoV-2 vaccine: a randomized clinical trial E Mostafavi, S Eybpoosh, M Karamouzian, M Khalili, S Haji-Maghsoudi, ... JAMA Network Open 6 (5), e2310302-e2310302, 2023 | 18 | 2023 |
| Whole exome sequencing identifies both nuclear and mitochondrial variations in an Iranian family with non-syndromic hearing loss S Khatami, H Rokni-Zadeh, N Mohsen-Pour, A Biglari, M Changi-Ashtiani, ... Mitochondrion 46, 321-325, 2019 | 15 | 2019 |
| Expression Level of Circulating miR-93 in Serum of Patients with Diabetic Nephropathy. M Akhbari, A Biglari, M Shahrabi-Farahani, M Khalili, F Bandarian Turkish Journal of Endocrinology & Metabolism 22 (2), 2018 | 15 | 2018 |
| PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals A Ramezani, R Sorouri, S Haji Maghsoudi, S Dahmardeh, D Doroud, ... Scientific Reports 13 (1), 8065, 2023 | 14 | 2023 |
